Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 AY, UK.
Eur J Pharm Sci. 2011 Mar 18;42(4):313-7. doi: 10.1016/j.ejps.2010.12.004. Epub 2010 Dec 21.
Multidrug resistance of bacterial pathogens is a major problem and there is a clear need for the development of new types of antibiotics. Here we investigated the antimicrobial activity of ruthenium(II) based DNA-intercalating complexes. These complexes were found to have no activity in vitro against the Gram-negative bacterium Escherichia coli, but the complexes were clearly active against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus. In vivo activity has also been demonstrated for one of the compounds using a simple infection model, the nematode Caenorhabditis elegans. Importantly, this also showed that the compound tested was not toxic to the nematodes.
细菌病原体的多药耐药性是一个主要问题,显然需要开发新型抗生素。在这里,我们研究了基于钌 (II) 的 DNA 嵌入配合物的抗菌活性。这些配合物在体外对革兰氏阴性菌大肠杆菌没有活性,但对革兰氏阳性菌枯草芽孢杆菌和金黄色葡萄球菌明显有活性。一种化合物在使用简单感染模型秀丽隐杆线虫的体内也表现出活性。重要的是,这也表明测试的化合物对线虫没有毒性。